In acute carbon monoxide (CO) intoxication, treatment of neurologic injury and prevention of neurological sequelae are primary concerns. Ethanol is the one of the frequent substances which is co-ingested in intentional CO poisoning. Neuroprotective effect of ethanol was highlighted and demonstrated in isolated brain injury recently. We assessed the neuroprotective effect of ethanol in acute CO intoxication using magnetic resonance imaging (MRI).
Introduction
Carbon monoxide (CO) intoxication is one of the frequent causes of morbidity and mortality due to poisoning, and is one of the main causes of poisoning-related deaths in the United States. [1, 2] Signs and symptoms of intoxication vary from mild headache, myalgia or dizziness to confusion, loss of consciousness, or death. [3] [4] [5] Even though mortality among patients admitted to the hospital has gradually decreased with time, until recently there has not been optimal methods to prevent and treat neurological injury. So, prevention and treatment of neurological injury and their sequelae have become the primary concerns in CO intoxication. [6] Several methods have been suggested to evaluate brain injuries caused by CO intoxication as a means of evaluating neurological injury and predicting sequelae. One objective assessment of brain injury is through magnetic resonance imaging (MRI), a readily available and minimally invasive procedure. [7] [8] [9] Coingestion of a second substance in patients with intentional CO poisoning occurs frequently, in almost 50% of patients, and involves ethanol (ETOH) in over two-thirds of patients. [10] In experimental and clinical studies, the neuroprotective effects of ETOH after isolated traumatic brain injury were postulated. Recent data have indicated the neuroprotective effects of ETOH in patients with moderate and traumatic brain injury. The mechanisms of this neuroprotective effect are inhibition of Nmethyl-D-aspartate (NMDA) receptor channels, mitigation of systemic catecholamine surge, reduction of aquaporin-4, inhibition of glycolysis, and lowering of body temperature. [11] [12] [13] [14] The aim of our study is to assess the neuroprotective effects of ETOH on neurological injury in acute CO intoxication by examination of brain lesions revealed by MRI.
Methods
This study was conducted retrospectively by reviewing medical records for patients who visited an emergency medical center of a university-affiliated hospital during a period of 73 months (March 2009 -April 2015 . This study was approved by the Institutional Review Board of Ajou University Medical Center (AJIRB-MED-MDB-16-477). Requirement of patient consent was waived due to the study's retrospective nature.
Enrolled patients and study setting
The enrolment criteria were diagnosis of acute CO poisoning and the measurement of the serum ETOH level and history of brain MRI during admission. The diagnosis of acute CO poisoning was established according to the history, clinical characteristics, physical examination, and blood carboxyhemoglobin levels > 3% in nonsmokers or >10% in smokers. The exclusion criteria were history of stroke, congenital brain anomaly, history of brain trauma, and surgery for avoiding false positives in the group selection process. Cases with missing or insufficient data were also excluded. The enrolled patients were divided into 2 groups: patients with or without abnormal brain lesion in T2-weighted imaging, fluid-attenuated inversion recovery (FLAIR) imaging, and diffusion weighted imaging (DWI). Any area of increased signal intensity in the T2 and FLAIR sequences was considered abnormal. Moreover, in DWI sequences, any area of high signal intensity in b value = 500 and b value = 1000 showing signal loss in apparent diffusion coefficient maps were considered abnormal. [15] To decide whether abnormal lesion is existed or not, the official readout data written by professional radiologist were reviewed (Fig. 1 ).
Data collection
Standardized extraction of demographic, clinical, laboratory, and radiological data using medical records was performed by 2 trained emergency physicians. Any discrepancy between the datasets extracted by 2 emergency physicians was resolved by a third physician. The physicians were blinded to the patient's serum laboratory study results. The sex and age of patients, symptoms and physical findings at presentation, electrocardiogram (ECG), and time interval from presentation at the emergency department (ED) to MRI were recorded. Laboratory studies including the evaluation of the serum levels of CO cardiac enzyme, S100 protein, ETOH, lactate, and pH were performed when the patient visited the ED. Serum ETOH level was measured using a quantitative chemistry analyzer (Roche Cobas Integra 800; Roche Diagnostics GmbH, Mannhaim, Germany). Conventional brain MRI and DWI was performed using a Philips 3.0 Teslon device (Philips North America Corperation, Andover, MA). T1 weighted (TR 400-500, TE 10, Slice thickness: 5 mm), T2 weighted (TR: 3100-3200, TE: 80), and FLAIR images (TR: 8000-10000, TE: 125) in sagittal, axial, and coronal sections and DWI in axial sections were performed for each patient.
Statistical analysis
The study population was divided into 2 groups: patients who tested positive for brain MRI (MRI lesion positive) and patients who tested negative for brain MRI (MRI lesion negative). All data are expressed as the mean ± standard deviations or the median (interquartile range) or using standard error, as appropriate. The significance of intergroup differences was assessed by Fisher exact 
Results

Comparisons of characteristics in the 2 groups
A total of 109 patients with acute CO intoxication were enrolled. Sixty-six (60.55%) were positive in brain MRI. Median age of patients was 39.21 ± 14.64 years and 65.14% (n = 71) were male.
Mean blood pressure was 89.53 ± 16.43 mm Hg and mean heart rate was 99.26 ± 22.27 beats per min. There were no significant differences in age, sex, and vital parameters between the 2 groups. MRI lesion positive patients were more likely to develop mental status changes (P <.05) compared with MRI lesion negative patients. There were no significant differences in clinical sign and symptoms on presentation and time interval from presentation on ED to MRI (Table 1) .
Comparisons of laboratory results between MRI lesion-positive and MRI lesion-negative patients
There were significant differences in serum lactate, serum S100 protein, serum cardiac enzyme levels, and serum ETOH levels between the 2 groups. Serum carboxyhemoglobin level and serum pH level did not differ significantly between the 2 groups ( Table 2) . 
Analysis for factors associated with positive MRI lesions
On univariate analysis, the significant factors associated with MRI lesion positivity were as follows: mental status (P <.05), serum lactate level (P <.05), ECG change (P <.05), serum ETOH positivity (P <.05), serum S100 level (P <.05), and serum troponin I level (P <.05). After adjusting for all confounding factors in a multivariate regression analysis, positive ETOH was an independent predictor for MRI lesion in patients with acute CO intoxication (Table 3) .
Distribution of brain lesion according to ETOH positivity
The most frequently injured area in brain of patients with acute CO intoxication was the white matter (WM) in ETOH-positive patients and the globus pallidus (GP) in ETOH-negative patients (Fig. 2 ).
Discussion
No clinical study about the neuroprotective effect of ETOH in acute CO intoxication has been reported to our knowledge.
Presently, acutely CO-intoxicated patients who had co-ingested ETOH had lower brain injury events in brain MRI. ETOH may have protective effect on brain injury in acute CO intoxication (odds ratio: 0.24, P <.05). ETOH intoxication was thought to be associated with worse outcomes generally. ETOH can be detrimental to the brain in several ways, including NMDA receptor supersensitivity followed by excitotoxicity, alcohol-induced oxidative stress of neurons, and promising growth factor secretion. [16] [17] [18] However, several beneficial effects of ETOH have been previously postulated by various mechanisms, which include inhibition of NMDA, moderation of systemic catecholamine surge, implied participation of aquaporin-4 in the development of cerebral edema suppression, reduction of hyperglycolysis, and lowering body temperature. [11] [12] [13] [14] Brain injuries caused by CO intoxication are explained by several pathophysiological mechanisms, which include dopamine excess followed by hypoxic stress, oxidative stress, lipid peroxidation, and catecholamine crisis. [6] One of the ETOH-related mechanisms could be a catecholamine crisis activated by sympathetic activities and the subsequent increase in catecholamine levels in synapses or nerve terminals, particularly in the limbic system in the brain. A neuroprotective effect of ETOH on brain injury in CO intoxication could derive Figure 2 . Distribution of brain lesion according to serum ethanol positivity. ETOH = ethanol, GP = globus pallidus, OBG = other basal ganglia, WM = white matter. CI = confidence interval, DBP = diastolic blood pressure, ECG = electrocardiogram, ETOH = ethanol, HR = heart rate, MBP = mean blood pressure, OR = odds ratio, SBP = systolic blood pressure.
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from the sedative effects of ETOH, which could mitigate the sympathetic activities and systemic catecholamine crisis. Dopamine excess followed by hypoxic stress, which could cause serotonergic axonal injury and secondary myelin damage in brain, may be reduced by ETOH. Some experimental studies have shown the inhibitory effect of ETOH on evoked dopamine neurotransmission in the brain. [19, 20] The neuroprotective effect of ETOH may also have been evident in the distribution of abnormal brain lesions according to serum ETOH positivity in our study (Fig. 2) . In acute CO intoxication, the GP is considered most vulnerable to catecholamine crisis, and the GP and other basal ganglia are commonly affected by brain lesions according to MRI analysis in the acute phase of CO intoxication. [9] Involvement of the GP is more frequent in ETOH-negative patients than in ETOH-positive patients. These differences in the distribution of brain lesions between ETOH positive group and ETOH negative patients may reflect the ETOH-related mitigation of the catecholamine crisis.
The other difference in the distribution of brain lesion which is the predominance of WM lesion in ETOH-positive patients may be also explained by the effect of ETOH. Even though the WM is frequently injured in acute CO intoxication, patients with ETOH consumption, whether acute or chronic, have also shown signal abnormalities in their WMs of brain in MRI studies. [24] And the protective effect of ETOH in GP which considered as mainstay could have elevated the portion of involvement of WM lesion as a result of the decrease portion of GP in ETOH-positive patients.
There were 6 laboratory parameters which are used for comparing 2 groups: MRI lesion-positive group and MRI lesionnegative group. Serum CO level which is generally considered as not related to neurologic injury after CO poisoning also did not show significant difference between groups. And no differences in serum pH level between groups imply that there was no significant distinction in acid-base status between the groups. Among the laboratory results in our study, the levels of serum S100 protein, serum troponin I, and lactate were elevated. These are considered as possible prognostic markers for delayed neurological sequelae (DNS). [21] [22] [23] DNS is characterized by variable degrees of cognitive deficits, personality changes, movement disorders, and focal neurologic deficits, which can arise 3 to 240 days after apparent recovery in acute CO intoxication. These predictive markers for DNS were significantly elevated in the MRI lesion positive group in our study. Elevations of these prognostic markers could imply more prevalence of DNS among MRI lesion positive patients.
We suggest that reduction of the prevalence of brain injury by a neuroprotective effect of ETOH in CO intoxication could be related to the finding of less abnormal brain MRI and may also be related to a lower prevalence of DNS.
This study has several limitations. It was a retrospective medical record review study rather than a randomized study. The relatively small sample size, caused by low frequency of disease and high price of MR devices, and lack of data about the duration of CO intoxication, co-intoxication of possible other drugs or gas, the neurological status of patients due to incompleteness of medical records, are also considered as study limitations. We could not confirm whether the brain injury existed or not based on abnormal brain MRI findings at a single phase after CO intoxication in our study. We also believe that the study model designed with subgroup analysis according to the chronicity of ETOH consumption would help to improve the reliability of our results and better understand the mechanism of ETOH protective effects on CO poisoning. More detailed study including serial evaluation of brain MRIs with proper time intervals and calculation of brain volume as a surrogate of chronic alcoholic MRI changes for further investigation will be needed in the future.
Conclusion
This study investigated the protective effect of ETOH in acute CO intoxication. Serum ETOH positivity was an independent predictor for brain injury in MRI. It reverses the myth that ETOH is harmful to the brain in cases of acute CO intoxication. We believe that ETOH co-ingestion in CO poisoning could have positive effects on DNS which is the primary concern in acute CO intoxication, recently. Further prospective studies are needed to assess whether ETOH truly prevents brain injury and DNS in acute CO intoxication.
